Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBSP3)
Sao Paulo Exchange · Brazil · prices in BRL · close of 22 Oct 2026
Key indicators
| Last close | BRL 31.80 |
|---|---|
| 52-week range | 23.17 – 35.32 |
| Return, 1 month / 3 months | +15.4% / +8.6% |
| Return, 1 year / 3 years | +29.3% / +198.2% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 30.2% |
| Worst drawdown (1 year) | -33.8% |
| Average daily value traded | 657.37M BRL |
| Dividend yield | 11.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Companhia de Saneamento Básico do Estado de São Paulo, known as Sabesp, is a water and wastewater utility based in the state of São Paulo, Brazil. It supplies drinking water, collects and treats sewage, and provides related sanitation services to households, businesses and public bodies across the municipalities it serves. The company operates reservoirs, treatment plants, pumping stations and distribution networks, and it also works on programmes to expand sanitation coverage and improve water quality in its service areas.
The shares are listed on the Sao Paulo Exchange in Brazil under the code SBSP3, and the price on this page is in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Companhia de Saneamento Básico do Estado de São Paulo - SABESP (SBSP3) trades on the Sao Paulo Exchange in Brazil. It last closed at BRL 31.80 on 22 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 360 of 1,454 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 29.3% and over the last three months it rose 8.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Sao Paulo Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 9.9% | ||
| From 52-week high | -9.7% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 8.6% | ||
| 6-month return | -8.0% | ||
| 12-month return, skipping the last month | 12.1% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -33.8% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 657.37M BRL | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 11.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −0.2% |
|---|---|
| 1 month | +15.4% |
| 3 months | +8.6% |
| 6 months | −8.0% |
| 1 year | +29.3% |
| 3 years | +198.2% |
| 5 years | +421.7% |
Signals
| 50-day / 200-day average | 27.64 / 28.92 |
|---|---|
| Golden / death cross (60 days) | Death, 51 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.89 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Mar 2026 | BRL 0.8347 |
| 23 Dec 2025 | BRL 2.7267 |
| 29 Apr 2025 | BRL 3.8472 |
| 25 Apr 2024 | BRL 1.4855 |
| 12 May 2023 | BRL 1.3159 |
| 28 Apr 2022 | BRL 0.9722 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Sao Paulo Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.